NCT06189001View on ClinicalTrials.gov

The Role of Oxytocin-receptor Signalling in Physiological Regulation of Eating Behaviour in Individuals with Obesity

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

September 4, 2024

Study Completion Date

September 4, 2024

Conditions

Adiposity

Interventions

DRUG

Oxytocin

Intravenous oxytocin 0.2 IU/min during experimental days

OTHER

Placebo (saline)

Intravenous saline during experimental days

Trial Locations (1)

2100

Center for Clinical Metabolisk Research, Hellerup

All Listed Sponsors

lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT06189001 - The Role of Oxytocin-receptor Signalling in Physiological Regulation of Eating Behaviour in Individuals with Obesity | Biotech Hunter | Biotech Hunter